dc.contributor.author | Toreci, K | |
dc.contributor.author | Kebudi, Rejin | |
dc.contributor.author | Akici, F | |
dc.contributor.author | Ayan, I | |
dc.contributor.author | Gorgun, O | |
dc.contributor.author | Gurler, N | |
dc.date.accessioned | 2021-03-04T13:57:12Z | |
dc.date.available | 2021-03-04T13:57:12Z | |
dc.date.issued | 2001 | |
dc.identifier.citation | Kebudi R., Gorgun O., Ayan I., Gurler N., Akici F., Toreci K., "Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors", MEDICAL AND PEDIATRIC ONCOLOGY, cilt.36, sa.4, ss.434-441, 2001 | |
dc.identifier.issn | 0098-1532 | |
dc.identifier.other | av_7f06a8b8-0789-4b72-a644-44e232ccd56a | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/86705 | |
dc.identifier.uri | https://doi.org/10.1002/mpo.1107 | |
dc.description.abstract | Background. With the availability of new broad-spectrum antibiotics, initial therapy with a single agent has become an alternative to classic combinations, especially beta -lactam antibiotics plus aminoglycosides, in the management of febrile neutropenic cancer patients. | |
dc.language.iso | eng | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Çocuk Sağlığı ve Hastalıkları | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | PEDİATRİ | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors | |
dc.type | Makale | |
dc.relation.journal | MEDICAL AND PEDIATRIC ONCOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 36 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 434 | |
dc.identifier.endpage | 441 | |
dc.contributor.firstauthorID | 161724 | |